Compound and composition for use in the treatment of premenstrual syndrome and/or premenstrual dysphoric disorder
BE1026955B1
Manufacturing process of magnesium N-acetyl-taurinate
EP3738596A1
Compound and composition for use in the treatment of premenstrual syndrome and/or premenstrual dysphoric disorder
BE1026496B1
Compound and composition for use in the treatment of premenstrual syndrome and / or premenstrual dysphoric disorder
EP3694505A1
Compound and composition for use in the preventive and/or curative treatment of diseases of the central nervous system characterised by a decline in neuronal plasticity, in particular characterised by a decline in synaptic plasticity
BE1025645A1
Compound for the treatment of neurotoxicity due to hyperexcitability of iototropic glutamatergic receptors
